Elekta AB (publ) (ST:EKTA-B) — Market Cap & Net Worth
Market Cap & Net Worth: Elekta AB (publ) (EKTA-B)
Elekta AB (publ) (ST:EKTA-B) has a market capitalization of $2.06 Billion (Skr19.18 Billion) as of September 17, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #6044 globally and #85 in its home market, demonstrating a 2.05% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Elekta AB (publ)'s stock price Skr52.25 by its total outstanding shares 367102351 (367.10 Million). Also see Elekta AB (publ) asset portfolio for a full breakdown of the balance sheet.
Elekta AB (publ) Market Cap History: 2015 to 2026
Elekta AB (publ)'s market capitalization history from 2015 to 2026. Data shows change from $2.38 Billion to $2.06 Billion (-0.28% CAGR). Also see how efficiently does Elekta AB (publ) generate cash for how efficiently the company converts equity into cash flow.
Elekta AB (publ) Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Elekta AB (publ)'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check EKTA-B live share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.12x
Elekta AB (publ)'s market cap is 0.12 times its annual revenue
Latest Price to Earnings (P/E) Ratio
9.46x
Elekta AB (publ)'s market cap is 9.46 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $2.67 Billion | $11.22 Billion | $137.00 Million | 0.24x | 19.50x |
| 2017 | $2.27 Billion | $10.70 Billion | $125.00 Million | 0.21x | 18.18x |
| 2018 | $3.59 Billion | $11.33 Billion | $1.10 Billion | 0.32x | 3.27x |
| 2019 | $4.26 Billion | $13.55 Billion | $1.20 Billion | 0.31x | 3.56x |
| 2020 | $3.88 Billion | $14.60 Billion | $1.08 Billion | 0.27x | 3.58x |
| 2021 | $4.10 Billion | $13.76 Billion | $1.25 Billion | 0.30x | 3.27x |
| 2022 | $2.32 Billion | $14.55 Billion | $1.15 Billion | 0.16x | 2.01x |
| 2023 | $3.14 Billion | $16.87 Billion | $943.00 Million | 0.19x | 3.33x |
| 2024 | $2.42 Billion | $18.12 Billion | $1.30 Billion | 0.13x | 1.86x |
| 2025 | $2.24 Billion | $18.02 Billion | $237.00 Million | 0.12x | 9.46x |
Competitor Companies of EKTA-B by Market Capitalization
Companies near Elekta AB (publ) in the global market cap rankings as of September 17, 2026. Review EKTA-B goodwill-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Elekta AB (publ) by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #125 globally with a market cap of $177.42 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #229 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #232 globally with a market cap of $107.98 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #125 | Abbott Laboratories | NYSE:ABT | $177.42 Billion | $102.03 |
| #229 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $93.75 |
| #232 | Stryker Corporation | NYSE:SYK | $107.98 Billion | $281.50 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Elekta AB (publ) Historical Marketcap From 2015 to 2026
Between 2015 and today, Elekta AB (publ)'s market cap moved from $2.38 Billion to $ 2.06 Billion, with a yearly change of -0.28%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr2.06 Billion | -7.93% |
| 2025 | Skr2.24 Billion | -7.20% |
| 2024 | Skr2.42 Billion | -23.11% |
| 2023 | Skr3.14 Billion | +35.34% |
| 2022 | Skr2.32 Billion | -43.34% |
| 2021 | Skr4.10 Billion | +5.54% |
| 2020 | Skr3.88 Billion | -8.95% |
| 2019 | Skr4.26 Billion | +18.71% |
| 2018 | Skr3.59 Billion | +58.03% |
| 2017 | Skr2.27 Billion | -14.93% |
| 2016 | Skr2.67 Billion | +12.17% |
| 2015 | Skr2.38 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Elekta AB (publ) was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.06 Billion USD |
| MoneyControl | $2.06 Billion USD |
| MarketWatch | $2.06 Billion USD |
| marketcap.company | $2.06 Billion USD |
| Reuters | $2.06 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Elekta AB (publ)
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear accelerator and radiation therapy products comprising Elekta Unity for anatomy-specific MR imaging; Elekta Evo that delivers offline and online adaptive radiation therapy; Elekta Versa … Read more